VALENZA, CARMINE
VALENZA, CARMINE
Dipartimento di Oncologia ed Emato-Oncologia
Extendeond Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients
2026 C. Valenza, Y. Zheng, M. Milano, P.P.M. Berton Giachetti, D. Trapani, E. Giordano, L. Guidi, L. Boldrini, G. Castellano, J. Katrini, B. Malagutti, G. Antonarelli, J.D. Etessami, N. Bianco, F. Conforti, G.J. Kirkner, C. Sangalli, K.E. Dibble, N. Fusco, M. Colleoni, M.M. Regan, E. Munzone, G. Curigliano, A.H. Partridge
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025
2026 E. Nicolò, F. Bertucci, H. Boussen, G. Curigliano, V. Fraser, L. Gerratana, S. Krishnamurthy, H.T. Le‐petross, B. Lim, F. Lynce, A. Lucci, S. Lucotti, M. Manai, S. Merajver, N. Missal, A. Nasrazadani, A. Soliman, C. Valenza, C. Van Berckelaer, S. Van Laere, W.A. Woodward, M. Cristofanilli, G. Devi
Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study
2026 N. Bianco, C. Valenza, M. Milano, R. Multinu, E. Battaiotto, M. Cavallone, G. Malvezzi, D. Trapani, P. Della Vigna, G. Bonomo, G.M. Varano, D. Maiettini, M.G. Pitoni, C. Sangalli, E. Munzone, G. Curigliano, M.A. Colleoni, F. Orsi
Advancing Antibody-Drug Conjugates: Current Perspectives and Future Directions
2026 J.D. Etessami, C. Valenza, A.W. Tolcher, P. Lorusso, G. Curigliano
Circulating tumor DNA: a biomarker for oncology drug development in phase I clinical trials?
2025 R. Asnaghi, R.M. Marsicano, V. Fuorivia, G. Malvezzi, J.D. Etessami, D. Izzo, C. Valenza, G. Curigliano, D. Trapani
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report
2025 F. Miglietta, M.G. Razeti, A. Caltavituro, A. Dri, C. Valenza, G. Bianchini, L. Biganzoli, A. Botticelli, M. Caruso, S. Cinieri, C. Criscitiello, C. De Angelis, M. De Laurentis, L. Del Mastro, S. De Placido, M. Del Re, M.V. Dieci, A. Fabi, D. Generali, A. Gennari, L. Gerratana, M. Giuliano, M. Lambertini, U. Malapelle, L. Malorni, I. Meattini, I. Paris, G. Pruneri, C. Zamagni, A. Zambelli, F.C. Bidard, V. Guarneri, F. Puglisi, G. Curigliano, G. Arpino
Metastasis-directed stereotactic radiotherapy and systemic treatment continuation for patients with oligoprogressive metastatic breast cancer
2025 M. Milano, C. Valenza, A. Ferrari, S. Gandini, D. Trapani, C. Santoro, E. Battaiotto, A. Carnevale Schianca, E. Giordano, J. Katrini, G. Castellano, B. Taurelli Salimbeni, M.C. Leonardi, S. Dicuonzo, C. Criscitiello, N. Bianco, S. Dellapasqua, E. Munzone, G. Curigliano, M. Colleoni, B.A. Jereczek-Fossa
Positioning oral selective estrogen receptor degraders in patients with metastatic breast cancer
2025 C. Valenza, G. Curigliano
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study
2025 C. Valenza, E. Nicolò, M. Mongillo, D. Trapani, J. Katrini, L. Boldrini, L. Boscolo Bielo, G. Castellano, L. Guidi, G. Pellizzari, J. Villa, S. Derio, M. Lapresa, F. Gigli, G. Parma, E. Omodeo Salè, E. Derenzini, G. Curigliano, N. Colombo
Bispecific Antibodies in Hematologic and Solid Tumors: Current Landscape and Therapeutic Advances
2025 L. Guidi, J. Etessami, C. Valenza, A. Valdivia, F. Meric-Bernstam, E. Felip, G. Curigliano
Beyond Boundaries in ERBB2-Positive Brain Metastatic Breast Cancer
2025 D. Trapani, C. Valenza, G. Curigliano
Role of Social Media for Medical Oncologists and Medical Oncology Fellows (SMARTY): An Italian Cross-Sectional Study
2025 E. Battaiotto, C. Valenza, M. Garutti, L.O. Molendini, E. Bellio, D. Trapani, F. Puglisi, G. Pravettoni, L. Buccoliero, G. Curigliano, M. Mazza
Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study
2025 C. Valenza, M. Mongillo, M.V. Visconti, J. Katrini, D. Trapani, L. Boldrini, L. Guidi, A. Farfalla, D. Malengo, G. Caruso, S. Derio, M. Lapresa, G. Parma, E. Biagioli, E. Omodeo Salé, G. Curigliano, N. Colombo
The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis
2025 C. Valenza, D. Trapani, F.M. Porta, E. Olmeda, A. Gaeta, L. Boscolo Bielo, F. Conversano, T.M. De Pas, G. Castellano, C. Santoro, E. Battaiotto, E. Mane, S. Coppola, F. Conforti, D. Mattar, S. Gandini, P. Veronesi, E. Guerini Rocco, E. Pennacchioli, G. Curigliano
Monitoring serum estradiol in premenopausal women with hormone receptor-positive breast cancer on adjuvant LHRH agonists
2025 C. Valenza, J.D. Etessami, E. Munzone, G. Pravettoni, G. Curigliano, D. Trapani
Sacituzumab govitecan in the first-line treatment of triple-negative breast cancer: balancing therapeutic sequencing with patient-relevant benefits
2025 D. Trapani, C. Valenza, G. Curigliano
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer
2024 L. Boscolo Bielo, D. Trapani, E. Nicolò, C. Valenza, L. Guidi, C. Belli, E. Kotteas, A. Marra, A. Prat, N. Fusco, C. Criscitiello, H.J. Burstein, G. Curigliano
PARP inhibitor resistant BRCA-mutated advanced breast cancer: current landscape and emerging treatments
2024 C. Valenza, R.M. Marsicano, D. Trapani, G. Curigliano
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population
2024 L. Mazzarella, F. Giugliano, E. Nicolo, A. Esposito, E. Crimini, G. Tini, J. Uliano, C. Corti, P. D'Amico, P.T. Aliaga, C. Valenza, M. Repetto, G. Antonarelli, L. Ascione, G. Vivanet, P.P.M. Berton Giachetti, I. Minchella, C. Belli, M. Locatelli, C. Criscitiello, G. Curigliano
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study
2024 C. Valenza, D. Trapani, P. Zagami, G. Antonarelli, L. Boscolo Bielo, E. Nicolò, J.M. Ribeiro, L. Guidi, C. Reduzzi, M. Spotti, L. Adamoli, J. Cortès, B. Pistilli, S.M. Tolaney, N. Ueno, R.M. Layman, M. Cristofanilli, L.A. Carey, E. Munzone, C. Criscitiello, F. Lynce, W.A. Woodward, G. Curigliano